Načítá se...
The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease
BACKGROUND: Relaxin/relaxin family peptide receptor 1 (RXFP1) signaling is important for both normal physiology and disease. Strong preclinical evidence supports relaxin as a potent antifibrotic molecule. However, relaxin‐based therapy failed in clinical trial in patients with systemic sclerosis. We...
Uloženo v:
| Vydáno v: | Mol Genet Genomic Med |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7196478/ https://ncbi.nlm.nih.gov/pubmed/32100955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.1194 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|